Zhitong Finance App News, Jiuzhou Express (600998.SH) announced that on December 25, 2025, Huiyuyuanhe (Hainan) Pharmaceutical Co., Ltd. (“Huiyu Yuanhe”), a subsidiary of the company's subsidiary, Beijing Jingfeng Pharmaceutical Group Co., Ltd. (“Jingfeng Pharmaceutical”), received the “Drug Registration Certificate” for promethazine hydrochloride injection approved and issued by the State Drug Administration.

Zhitong Finance App News, Jiuzhou Express (600998.SH) announced that on December 25, 2025, Huiyuyuanhe (Hainan) Pharmaceutical Co., Ltd. (“Huiyu Yuanhe”), a subsidiary of the company's subsidiary, Beijing Jingfeng Pharmaceutical Group Co., Ltd. (“Jingfeng Pharmaceutical”), received the “Drug Registration Certificate” for promethazine hydrochloride injection approved and issued by the State Drug Administration.